Conjugates containing hydrophilic spacer linkers
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- ENDOCTYE INC
- Publication Date
- 2014-03-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority under 35 U.S.C. §119(e) of U.S. provisional patent application Ser. Nos. 60 / 946,092 and 61 / 036,186, filed Jun. 25, 2007 and Mar. 13, 2008, respectively; the disclosures of which are incorporated herein in their entirety by reference.TECHNICAL FIELD
[0002] The present invention relates to compositions and methods for use in targeted drug delivery. More particularly, the invention is directed to cell-surface receptor binding drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations and to methods and pharmaceutical compositions that use and include such conjugates.BACKGROUND
[0003] The mammalian immune system provides a means for the recognition and elimination of tumor cells, other pathogenic cells, and invading foreign pathogens. While the immune system normally provides a strong line of defense, there are many instanc...